Research has been published on the use of nanotherapeutics to enhance cancer treatment, specifically focusing on regulated cell death and sonodynamic anti-tumor immune responses. The study appears to be related to broader advancements in cancer immunotherapy, including the development of metal-organic frameworks and other nanomedicines. Various recent studies and reviews have explored the mechanisms, applications, and prospects of these emerging therapies in cancer treatment.